Selkirk Pharma introduces ClinFAST™ to expedite fill/finish for clinical trials
Selkirk Pharma, a contract manufacturing organization (CMO) based in Spokane, today announced the launch of ClinFAST™, a paradigm-shifting service designed to assist clinical stage biotech and pharma companies with a rapid fill/finish process for clinical trial supplies.
The traditional fill/finish landscape presents major hurdles for small-volume projects, with waiting periods ranging from 6 to 12 months for an available slot. ClinFAST eliminates these delays by running production processes in parallel and leveraging a templated approach that streamlines each step—from compounding to final release.
With the unveiling of ClinFAST, Selkirk Pharma strengthens Washington state’s expansive network of CMOs focused on reducing production bottlenecks and accelerating the delivery of life-saving treatments.